Sign In
Buy REGN
$628.73
+9.78 (+1.58%)
At Close: Jun 04, 2026
Dupixent® (dupilumab) Late-Breaking Data at AAD Show Significant Improvements in Signs and Symptoms of Moderate-to-severe Atopic Hand and Foot Dermatitis
02:00pm, Saturday, 18'th Mar 2023 GlobeNewswire Inc.
More than twice as many patients on Dupixent achieved clear or almost clear skin compared to placebo at 16 weeks
Regeneron (REGN) Gains 9.3% in a Year: Will the Uptrend Last?
04:17pm, Friday, 17'th Mar 2023 Zacks Investment Research
Regeneron (REGN) has had a good run in the past 12 months and the momentum should continue in 2023 on the back of growth in Dupixent, as Eylea faces challenges.
Regeneron (REGN) Gains 9.3% in a Year: Will the Uptrend Last?
01:45pm, Friday, 17'th Mar 2023
Regeneron (REGN) has had a good run in the past 12 months and the momentum should continue in 2023 on the back of growth in Dupixent, as Eylea faces challenges.
Medicare Negotiation Undercuts Biotech Stocks Regeneron, Halozyme
10:50am, Friday, 17'th Mar 2023
Confusion over new Centers for Medicare and Medicaid Services negotiating plans sent REGN and HALO stocks tumbling Thursday. The post Medicare Negotiation Undercuts Biotech Stocks Regeneron, Halozyme
2 Biotech Stocks To Watch In March 2022
05:52pm, Thursday, 16'th Mar 2023
Check out these 2 biotech stocks in the stock market today.
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
12:05pm, Thursday, 16'th Mar 2023
Confusion over new Centers for Medicare and Medicaid Services negotiating plans sent REGN and HALO stocks tumbling Thursday. The post Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme ap
Regeneron (REGN) Dips More Than Broader Markets: What You Should Know
10:15pm, Wednesday, 15'th Mar 2023 Zacks Investment Research
In the latest trading session, Regeneron (REGN) closed at $760.30, marking a -0.85% move from the previous day.
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Barclays Global Healthcare Conference (Transcript)
11:39am, Wednesday, 15'th Mar 2023
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Barclays Global Healthcare Conference March 15, 2023 9:00 AM ET Company Participants Ryan Crowe - Vice President of Investor Relations Robert Landry - Ch
Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease
01:30am, Wednesday, 15'th Mar 2023 GlobeNewswire Inc.
$250,000 top award goes to Neel Moudgal in the nation’s oldest and most prestigious science and math competition for high school seniors $250,000 top award goes to Neel Moudgal in the nation’s old
Should You Invest in the iShares Biotechnology ETF (IBB)?
10:20am, Tuesday, 14'th Mar 2023 Zacks Investment Research
Sector ETF report for IBB
The Zacks Analyst Blog Highlights NVIDIA, McDonald's, Intuit, AT&T and Regeneron Pharmaceuticals
02:57pm, Monday, 13'th Mar 2023 Zacks Investment Research
NVIDIA, McDonald's, Intuit, AT&T and Regeneron Pharmaceuticals are part of the Zacks top Analyst Blog
Regeneron Borrows From Big Pharma Playbook
10:00am, Saturday, 11'th Mar 2023
Eylea, the company's top-selling blockbuster, isn't going away soon.
Top Analyst Reports for NVIDIA, McDonald's & Intuit
06:09pm, Friday, 10'th Mar 2023 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), McDonald's Corporation (MCD) and Intuit Inc. (INTU).
Regeneron (REGN) Stock Moves -0.19%: What You Should Know
11:15pm, Thursday, 09'th Mar 2023 Zacks Investment Research
Regeneron (REGN) closed the most recent trading day at $743.75, moving -0.19% from the previous trading session.
Investing in Top CRISPR Companies
10:39pm, Thursday, 09'th Mar 2023 The Motley Fool
These CRISPR stocks could be big winners for patient investors.
